Targeting immunosenescence: a new frontier for mineralocorticoid receptor antagonism in chronic kidney disease
- PMID: 41455066
- DOI: 10.1007/s11255-025-04960-x
Targeting immunosenescence: a new frontier for mineralocorticoid receptor antagonism in chronic kidney disease
Conflict of interest statement
Declarations. Conflict of interest: The authors have declared that no conflict of interest exists. Human and animal rights: This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent: Informed consent was obtained from all individual participants included in the study.
Comment on
-
Mineralocorticoid receptor antagonists promote renal immunosenescence.Int Urol Nephrol. 2025 Oct;57(10):3299-3306. doi: 10.1007/s11255-025-04530-1. Epub 2025 Apr 30. Int Urol Nephrol. 2025. PMID: 40304997 Free PMC article. Review.
References
Reference
-
- Wang QR, Yang Y (2025) Mineralocorticoid receptor antagonists promote renal immunosenescence. Int Urol Nephrol 57:3299–3306. https://doi.org/10.1007/s11255-025-04530-1 - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources
